Senores Pharmaceuticals Board Meeting on 14/05/2026

Senores Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026. The trading window for dealing in the company's securities has been closed since April 1, 2026, and will remain closed until 48 hours after the results are approved and submitted to stock exchanges.